Polyrizon Files New US Divisional Patent Application With USPTO, Further Expanding Its IP Portfolio Relating To Proprietary Mucoadhesive Technology

Polyrizon Ltd. has filed a new U.S. divisional patent application with the USPTO, expanding its intellectual property portfolio related to its proprietary mucoadhesive technology for nasal drug delivery. The application, titled 'Mucoadhesive Polymers for Nasal Drug Delivery' (U.S. Patent Application No. 19/823,285), aims to enhance the company's existing patent family and supports various applications for delivering therapeutic agents through mucosal tissues. This move allows Polyrizon to seek additional patent protection for specific aspects of its technology.